Central North Airport Group, also known as Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (OMA), has announced its financial and operational results for the third quarter of 2026. The report highlights significant growth in passenger traffic and revenue, marking a positive trajectory for the company and the airport sector as a whole.
The company reported a 1.3% increase in passenger traffic, reaching 7.7 million passengers in Q3 2026 compared to the same period in 2025. This growth is attributed to strong performance at several airports, including San Luis Potosi, Durango, and Chihuahua.
Company Overview
Central North Airport Group operates under the SIC classification 4581, which covers airports, flying fields, and airport terminal services. The company is listed on the Nasdaq and OTC exchanges under the tickers OMAB and GAERF, respectively. As a large accelerated filer, OMA has been actively reporting its financials, with the latest filing dated October 28, 2026.
What the Filing Says
The filing reveals that the sum of aeronautical and non-aeronautical revenues grew by 8.3% compared to Q3 2025. Adjusted EBITDA also saw an increase of 8.7%, reaching Ps.2,883 million. The report indicates that capital investments for the quarter amounted to Ps.1,138 million, reflecting the company's commitment to infrastructure development.
Impact
The results are likely to affect various stakeholders, including investors, employees, and competitors in the airport services industry. The growth in passenger traffic and revenue may prompt competitors to enhance their own services and operational efficiencies to remain competitive.
What's Next
The filing does not specify what happens next for the company, but it is expected that OMA will continue to focus on expanding its services and improving passenger experience in the coming quarters.
Read Next
AEP Texas reports Q3 results, highlights operational strength
Infosys reports Q2 2026 results with modest growth in revenues
Capitol Federal Financial Reports Strong Q4 Earnings Results
Genmab Reports Positive Phase 3 Results for Petosemtamab
Amphenol announces dividend increase, new stock buyback plan
LCI Industries confirms unsolicited acquisition proposal










